Tutorials
Rani Therapeutics Holdings Inc logo

Rani Therapeutics Holdings Inc

$ 11.32 +3.09 (+37.55%) 08:09 PM EST
P/E:
At Loss
P/B:
5.17
Market Cap:
$ 277.25M
Enterprise V:
$ 181.07M
Volume:
891.87K
Avg Vol (2M):
72.06K
Volume:
891.87K
Market Cap $:
277.25M
PE Ratio:
At Loss
Avg Vol (2-Month):
72.06K
Enterprise Value $:
181.07M
PB Ratio:
5.17
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Rani Therapeutics Holdings Inc
NAICS : 541713 SIC : 2833
2051 Ringwood Avenue, San Jose, CA, USA, 95131
Description
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
Name Current Vs Industry Vs History
Cash-To-Debt 93.05
Equity-to-Asset 0.46
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 34.85
Distress
Grey
Safe
Beneish M-Score -1.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 52.92
9-Day RSI 50.32
14-Day RSI 49.87
6-1 Month Momentum % -26.85
12-1 Month Momentum % -30.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 26.29
Quick Ratio 26.29
Cash Ratio 25.95

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -3068.89
Net Margin % -1021.88
ROA % -18.7
ROIC % -786.58
ROC (Joel Greenblatt) % -1261.25
ROCE % -60.09

Financials (Next Earnings Date:2022-11-15 Est.)

RANI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:RANI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.961
EPS (TTM) ($) -1.012
Beta 0
Volatility % 103.61
14-Day RSI 49.87
14-Day ATR ($) 1.322065
20-Day SMA ($) 11.53225
12-1 Month Momentum % -30.75
52-Week Range ($) 8 - 36.27
Shares Outstanding (Mil) 24.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rani Therapeutics Holdings Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More